Arbutus Biopharma Corporation
NasdaqGS:ABUS
$ 2.69
$-0.04 (-1.47%)
$ 2.69
$-0.04 (-1.47%)
End-of-day quote: 05/01/2024

ABUS - Arbutus Biopharma Stock Prediction 2025 - 2030

13 years of reliable Arbutus Biopharma stock forecast. The Wall Street analysts predict Outperform for ABUS. See at a glance whether NasdaqGS:ABUS will rise in the future.

$0.00
Forecast 2023
$3.21
Forecast 2025
$5.46
Forecast 2030
Underperform
TopGraphs Quality Ranking
Forecast 2023
$0.00
Forecast 2025
$3.21
Forecast 2030
$5.46
TopGraphs Quality Ranking
Underperform

Company Info

P/E
0.00
Beta
2.09
Price-to-book Ratio
4.34
Market Cap
0.49B
TEV
0.34 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$6.34

Arbutus Biopharma Price Chart

1M 3M YTD 1Y 2Y 5Y 10Y 20Y

Arbutus Biopharma Stock Forecast 2023

$5.43

In the last five quarters, Arbutus Biopharma’s Price Target has fallen from $8.83 to $6.34 - a -28.2% decrease. Five analysts predict that Arbutus Biopharma’s share price will fall in the coming year, reaching $5.43. This would represent a decrease of -14.35%.

101.86%
101.86
Last update: 05/02/2024

Highest Price Target $6.79

Average Price Target $5.43

Lowest Price Target $5.41

Arbutus Biopharma Stock Forecast 2025

Stock Prediction for the Price of One Arbutus Biopharma Share in Jan 2025.

In Jan 2025 analysts predict a share price of $2.92. An increase of 8.42% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Feb 2025.

In Feb 2025 analysts predict a share price of $2.94. An increase of 9.42% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Mar 2025.

In Mar 2025 analysts predict a share price of $2.97. An increase of 10.42% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Apr 2025.

In Apr 2025 analysts predict a share price of $3.00. An increase of 11.43% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in May 2025.

In May 2025 analysts predict a share price of $3.02. An increase of 12.43% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Jun 2025.

In Jun 2025 analysts predict a share price of $3.05. An increase of 13.43% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Jul 2025.

In Jul 2025 analysts predict a share price of $3.08. An increase of 14.43% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Aug 2025.

In Aug 2025 analysts predict a share price of $3.11. An increase of 15.43% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Sep 2025.

In Sep 2025 analysts predict a share price of $3.13. An increase of 16.43% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Oct 2025.

In Oct 2025 analysts predict a share price of $3.16. An increase of 17.44% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Nov 2025.

In Nov 2025 analysts predict a share price of $3.19. An increase of 18.44% compared to today's share price.

Stock Prediction for the Price of One Arbutus Biopharma Share in Dec 2025.

In Dec 2025 analysts predict a share price of $3.21. An increase of 19.44% compared to today's share price.

Arbutus Biopharma Stock Predictions 2030

Arbutus Biopharma Stock Predictions for Jan 2030.

In January 2030 analysts predict a stock price of $4.96. An increase of 84.26% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Feb 2030.

In February 2030 analysts predict a stock price of $5.00. An increase of 85.97% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Mar 2030.

In March 2030 analysts predict a stock price of $5.05. An increase of 87.67% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Apr 2030.

In April 2030 analysts predict a stock price of $5.09. An increase of 89.37% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for May 2030.

In May 2030 analysts predict a stock price of $5.14. An increase of 91.07% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Jun 2030.

In June 2030 analysts predict a stock price of $5.19. An increase of 92.78% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Jul 2030.

In July 2030 analysts predict a stock price of $5.23. An increase of 94.48% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Aug 2030.

In August 2030 analysts predict a stock price of $5.28. An increase of 96.18% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Sep 2030.

In September 2030 analysts predict a stock price of $5.32. An increase of 97.88% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Oct 2030.

In October 2030 analysts predict a stock price of $5.37. An increase of 99.58% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Nov 2030.

In November 2030 analysts predict a stock price of $5.41. An increase of 101.29% compared to the previous month's estimate.

Arbutus Biopharma Stock Predictions for Dec 2030.

In December 2030 analysts predict a stock price of $5.46. An increase of 102.99% compared to the previous month's estimate.

P/E
0.00
Beta
2.09
Price-to-book Ratio
4.34
Market Cap
0.49B
TEV
0.34 B
Dividend
$0.00
Div Yld
0.00%
Forecast 1Y
0.00%
Forecast 2Y
0.00%
Analyst Price Target
$6.34

Arbutus Biopharma Analyst Ratings Frequently Asked Questions

Who are the analysts watching Arbutus Biopharma Corporation?

The following analysts have recently covered Arbutus Biopharma:

Baird
Chardan Capital Markets, LLC
H.C. Wainwright & Co.
Jefferies LLC
JMP Securities
Marktfeld
(This information refers to the last 90 days.)

Who are the sell-side analysts watching Arbutus Biopharma Corporation?

The following sell-side analysts have recently covered Arbutus Biopharma:

Skorney, Brian Peter
Nakae, Keay Thomas
Arce, Antonio Eduardo
Ding, Yuchen
Buchanan, Douglas Royal
Paraskevopoulos, Michail
(This information refers to the last 90 days.)